Related references
Note: Only part of the references are listed.Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
Ruben P. A. van Eijk et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis
Wouter Van Rheenen et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Sialorrhoea and reversals in ALS functional rating scale
Susana Pinto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe et al.
LANCET NEUROLOGY (2017)
Complete hazard ranking to analyze right-censored data: An ALS survival study
Zhengnan Huang et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression
Benjamin J. Murdock et al.
JAMA NEUROLOGY (2017)
Stratification of ALS patients' survival: a population-based study
Benoit Marin et al.
JOURNAL OF NEUROLOGY (2016)
How common are ALS plateaus and reversals?
Richard S. Bedlack et al.
NEUROLOGY (2016)
Classifying change and heterogeneity in amyotrophic lateral sclerosis
Giancarlo Logroscino
LANCET NEUROLOGY (2016)
Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population
Mfon E. Umoh et al.
NEUROLOGY (2016)
A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis
David P. Noren et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis
Isabella Fogh et al.
JAMA NEUROLOGY (2016)
Predicting disease progression in amyotrophic lateral sclerosis
Albert A. Taylor et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis
Benjamin J. Murdock et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm
Marwa Elamin et al.
JOURNAL OF NEUROLOGY (2015)
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Neta Zach et al.
NEUROTHERAPEUTICS (2015)
Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge
Kahn Rhrissorrakrai et al.
BIOINFORMATICS (2015)
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
Adriano Chio et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression
Robert Kueffner et al.
NATURE BIOTECHNOLOGY (2015)
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2014)
The phenotypic variability of amyotrophic lateral sclerosis
Bart Swinnen et al.
NATURE REVIEWS NEUROLOGY (2014)
An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis
Xueping Chen et al.
NEUROLOGICAL SCIENCES (2014)
The PRO-ACT database Design, initial analyses, and predictive features
Nazem Atassi et al.
NEUROLOGY (2014)
Physiology of Geobacter metallireducens under excess and limitation of electron donors. Part I. Batch cultivation with excess of carbon sources
Sviatlana Marozava et al.
SYSTEMATIC AND APPLIED MICROBIOLOGY (2014)
A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS
Michael E. Bozik et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine A Population-Based Study
Adriano Chio et al.
JAMA NEUROLOGY (2014)
Clinical and genetic heterogeneity of amyotrophic lateral sclerosis
M. Sabatelli et al.
CLINICAL GENETICS (2013)
Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
Kevin P. Kenna et al.
JOURNAL OF MEDICAL GENETICS (2013)
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2013)
Controversies and priorities in amyotrophic lateral sclerosis
Martin R. Turner et al.
LANCET NEUROLOGY (2013)
Uric acid levels predict survival in men with amyotrophic lateral sclerosis
Sabrina Paganoni et al.
JOURNAL OF NEUROLOGY (2012)
What does body mass index measure in amyotrophic lateral sclerosis and why should we care?
Sabrina Paganoni et al.
MUSCLE & NERVE (2012)
Wisdom of crowds for robust gene network inference
Daniel Marbach et al.
NATURE METHODS (2012)
The self-assessment trap: can we all be better than average?
Raquel Norel et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
BODY MASS INDEX, NOT DYSLIPIDEMIA, IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS
Sabrina Paganoni et al.
MUSCLE & NERVE (2011)
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Swati P. Aggarwal et al.
LANCET NEUROLOGY (2010)
Factors associated with survival in the National Registry of Veterans with ALS
Daniel M. Pastula et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis
Mamede De Carvalho et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Phase II Trial of CoQ10 for ALS Finds Insufficient Evidence to Justify Phase III
Petra Kaufmann et al.
ANNALS OF NEUROLOGY (2009)
ALS motor phenotype heterogeneity, focality, and spread Deconstructing motor neuron degeneration
John M. Ravits et al.
NEUROLOGY (2009)
Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups
Jeban Ganesalingam et al.
PLOS ONE (2009)
Causes of death in a post-mortem series of ALS patients
Philippe Corcia et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C
Alessandra Calabria Baxmann et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
ALSFRS-R score and its ratio: A useful predictor for ALS-progression
Katja Kollewe et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival
Robert L. Vender et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Amyotrophic lateral sclerosis: early predictors of prolonged survival
Adam Czaplinski et al.
JOURNAL OF NEUROLOGY (2006)
Functional outcome measures as clinical trial endpoints in ALS
BJ Traynor et al.
NEUROLOGY (2004)
Prognosis in amyotrophic lateral sclerosis - A population-based study
MA del Aguila et al.
NEUROLOGY (2003)
Disease progression in amyotrophic lateral sclerosis: Predictors of survival
T Magnus et al.
MUSCLE & NERVE (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
